Anders Rosén
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- T-cell and B-cell Immunology
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Immunology 56
- Immunodeficiency and Autoimmune Disorders 20
- T-cell and B-cell Immunology 13
- Genetics 27
- Chronic Lymphocytic Leukemia Research 25
- Co-authors
- George KleinAnita SöderbergBita SahafB BeermannMikael JondalP GergelySven BrittonKjell Hellström
In The Last Decade
Anders Rosén
199 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 155
- Immunology 1.6k
- Genetics 786
- Pathology and Forensic Medicine 797
- Oncology 1.1k
- Reproductive Medicine 322
Countries citing papers authored by Anders Rosén
This map shows the geographic impact of Anders Rosén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Rosén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Rosén more than expected).
Fields of papers citing papers by Anders Rosén
This network shows the impact of papers produced by Anders Rosén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Rosén. The network helps show where Anders Rosén may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anders Rosén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 34 | |
| 5 | 2018 | 1 | |
| 6 | 2012 | 20 | |
| 7 | 2012 | 84 | |
| 8 | 2004 | 80 | |
| 9 | 2003 | 48 | |
| 10 | 2002 | 12 | |
| 11 | 1996 | 4 | |
| 12 | 1996 | 42 | |
| 13 | 1994 | 19 | |
| 14 | 1994 | 12 | |
| 15 | 1993 | 50 | |
| 16 | 1990 | 2 | |
| 17 | 1990 | 2 | |
| 18 | 1989 | 54 | |
| 19 | 1988 | 0 | |
| 20 | 1987 | 5 |
About Anders Rosén
Anders Rosén is a scholar working on Immunology, Genetics, Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 202 papers that have together received 6.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (25 papers), Lymphoma Diagnosis and Treatment (21 papers), Immunodeficiency and Autoimmune Disorders (20 papers), Viral-associated cancers and disorders (19 papers), Ovarian cancer diagnosis and treatment (17 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), T-cell and B-cell Immunology (13 papers) and Redox biology and oxidative stress (12 papers). The work is most often cited by research in Immunology (1.6k citations), Genetics (786 citations), Pathology and Forensic Medicine (797 citations), Oncology (1.1k citations) and Reproductive Medicine (322 citations). Anders Rosén has collaborated with scholars based in Sweden, Austria and Germany. Frequent co-authors include George Klein, Anita Söderberg, Bita Sahaf, B Beermann, Mikael Jondal, P Gergely, Sven Britton, Kjell Hellström, Urban Alehagen and Arne Holmgren. Their work appears in journals such as International Journal of Cancer, Archives of Gynecology and Obstetrics, Medical Microbiology and Immunology, Journal of Immunological Methods and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.